Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 249

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Open science saves lives: lessons from the COVID-19 pandemic

Open access
Besançon, Lonni, Peiffer-Smadja, Nathan, Segalas, Corentin, Jiang, Haiting, Masuzzo, Paola, Smout, Cooper, Billy, Eric, Deforet, Maxime, Leyrat, Clémence · 2021 · BMC Medical Research Methodology

Published version of a preprint

Abstract

In the last decade Open Science principles have been successfully advocated for and are being slowly adopted in different research communities. In response to the COVID-19 pandemic many publishers and researchers have sped up their adoption of Open Science practices, sometimes embracing them fully and sometimes partially or in a sub-optimal manner. In this article, we express concerns about the violation of some of the Open Science principles and its potential impact on the quality of research output. We provide evidence of the misuses of these principles at different stages of the scientific process. We call for a wider adoption of Open Science practices in the hope that this work will encourage a broader endorsement of Open Science principles and serve as a reminder that science should always be a rigorous process, reliable and transparent, especially in the context of a pandemic where research findings are being translated into practice even more rapidly. We provide all data and scripts at https://osf.io/renxy/ .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12874-021-01304-y

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 81

  1. Glasziou PP, Sanders S, Hoffmann T. Waste in covid-19 research. BMJ. 2020; 369:m1847. https://doi.org/10.1136/bmj.m1847. · DOI · Paper page
  2. Yeo-Teh NSL, Tang BL. An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19). Accountability Res. 2020:1–7. https://doi.org/10.1080/08989621.2020.1782203. PMID: 32573274. · DOI
  3. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. The Lancet. 2009; 374(9683):86–9. https://doi.org/10.1016/S0140-6736(09)60329-9. · DOI · Paper page
  4. Allen C, Mehler DMA. Open science challenges, benefits and tips in early career and beyond. PLoS Biol. 2019; 17(5):1–14. https://doi.org/10.1371/journal.pbio.3000246. · DOI · Paper page
  5. Cockburn A, Dragicevic P, Besançon L, Gutwin C. Threats of a replication crisis in empirical computer science. Commun ACM. 2020; 63(8):70–9. https://doi.org/10.1145/3360311. · DOI
  6. Smaldino PE, Turner MA, Contreras Kallens PA. Open science and modified funding lotteries can impede the natural selection of bad science. R Soc Open Sci. 2019; 6(7):190194. https://doi.org/10.1098/rsos.190194. · DOI
  7. Masuzzo P, Martens L. Do you speak open science? Resources and tips to learn the language. PeerJ Preprints. 2017; 5:2689–1. https://doi.org/10.7287/peerj.preprints.2689v1. · doi:10.7287/peerj.preprints.2689v1
  8. Watson M. When will ‘open science’ become simply ‘science’?Genome Biol. 2015; 16(1):1–3. https://doi.org/10.1186/s13059-015-0669-2. · DOI
  9. Sarabipour S, Debat HJ, Emmott E, Burgess SJ, Schwessinger B, Hensel Z. On the value of preprints: An early career researcher perspective. PLoS Biol. 2019; 17(2):1–12. https://doi.org/10.1371/journal.pbio.3000151. · DOI · Paper page
  10. Goecks J, Nekrutenko A, Taylor J, The Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 2010; 11(8):86. https://doi.org/10.1186/gb-2010-11-8-r86. · DOI · Paper page
  11. Besançon L, Rönnberg N, Löwgren J, Tennant JP, Cooper M. Open up: a survey on open and non-anonymized peer reviewing. Res Integr Peer Rev. 2020; 5(1):1–11. https://doi.org/10.1186/s41073-020-00094-z. · DOI
  12. Snell L, Spencer J. Reviewers’ perceptions of the peer review process for a medical education journal. Med Educ. 2005; 39(1):90–7. https://doi.org/10.1111/j.1365-2929.2004.02026.x. · DOI
  13. COVID-19 resources for librarians, campuses and health professionals (March 24, 2020). https://www.elsevier.com/connect/coronavirus-initiatives. (2020, Accessed 20 April 2021).
  14. Fraser N, Brierley L, Dey G, Polka JK, Pálfy M, Coates JA. Preprinting a pandemic: the role of preprints in the COVID-19 pandemic. bioRxiv. 2020. https://doi.org/10.1101/2020.05.22.111294. · DOI
  15. Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of covid-19: a multinational registry analysis. The Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)31180-6. · DOI · Paper page
  16. Wolkewitz M, Puljak L. Methodological challenges of analysing COVID-19 data during the pandemic. BMC Med Res Methodol. 2020; 20(81). https://doi.org/10.1186/s12874-020-00972-6. · DOI
  17. Rosendaal FR. Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al. 2010. Int J Antimicrob Agents. 2020; 56(1):106063. https://doi.org/10.1016/j.ijantimicag.2020.106063. · DOI
  18. Is France’s president fueling the hype over an unproven coronavirus treatment? 2020. https://www.sciencemag.org https: //www.sciencemag.org/news/2020/04/france-s-president-fueling-hype-over-unproven-coronavirus-treatment. Accessed 20 July 2020.
  19. Ledford H. Coronavirus shuts down trials of drugs for multiple other diseases. Nature. 2020; 580(7801):15–7. https://doi.org/10.1038/d41586-020-00889-6. · DOI
  20. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain J-M, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949. · DOI · Paper page
  21. Xafis V, Schaefer GO, Labude MK, Zhu Y, Hsu LY. The perfect moral storm: Diverse ethical considerations in the COVID-19 pandemic. Asian Bioeth Rev. 2020; 46(12):803–7. https://doi.org/10.1007/s41649-020-00125-3. · DOI
  22. Nguyen LS, Dolladille C, Drici M-D, Fenioux C, Alexandre J, Mira J-P, Moslehi JJ, Roden DM, Funck-Brentano C, Salem J-E. Cardiovascular toxicities associated with hydroxychloroquine and azithromycin. Circulation. 2020; 142(3):303–5. https://doi.org/10.1161/CIRCULATIONAHA.120.048238. · DOI
  23. Bramstedt KA. The carnage of substandard research during the COVID-19 pandemic: a call for quality. J Med Ethics. 2020; 46:803–7. https://doi.org/10.1136/medethics-2020-106494. · DOI · Paper page
  24. Cockburn A, Gutwin C, Dix A. Hark no more: On the preregistration of chi experiments. In: Proceedings of the 2018 CHI Conference on Human Factors in Computing Systems CHI ’18. New York, NY, USA: Association for Computing Machinery: 2018. p. 1–12. https://doi.org/10.1145/3173574.3173715. · DOI
  25. Reveiz L, Cortés-Jofré M, Asenjo Lobos C, Nicita G, Ciapponi A, Garcìa-Dieguez M, Tellez D, Delgado M, Solà I, Ospina E. Influence of trial registration on reporting quality of randomized trials: Study from highest ranked journals. J Clin Epidemiol. 2010; 63(11):1216–22. https://doi.org/10.1016/j.jclinepi.2010.01.013. · DOI
  26. Dodd LE, Follmann D, Wang J, Koenig F, Korn LL, Schoergenhofer C, Proschan M, Hunsberger S, Bonnett T, Makowski M, Belhadi D, Wang Y, Cao B, Mentre F, Jaki T. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clin Trials. 2020; 17(5):472–82. https://doi.org/10.1177/1740774520939938. · DOI
  27. Wagenmakers E-J, Dutilh G, Sarafoglou A. The creativity-verification cycle in psychological science: New methods to combat old idols. Perspect Psychol Sci. 2018; 13(4):418–27. https://doi.org/10.1177/1745691618771357. PMID: 29961413. · DOI
  28. Wiseman R, Watt C, Kornbrot D. Registered reports: an early example and analysis. PeerJ. 2019; 7:6232. https://doi.org/10.7717/peerj.6232. · DOI
  29. Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806–8. https://doi.org/10.1136/bmj.39335.541782.AD. · DOI · Paper page
  30. LeBlanc AG, Barnes JD, Saunders TJ, Tremblay MS, Chaput J-P. Scientific sinkhole: The pernicious price of formatting. PLoS ONE. 2019; 14(9):1–7. https://doi.org/10.1371/journal.pone.0223116. · DOI
  31. Pain E. Meet Octopus, a new vision for scientific publishing. https://www.sciencemag.org/careers/2018/11/meet-octopus-new-vision-scientific-publishing. Accessed 20 July 2020. · doi:10.1126/science.caredit.aav9309
  32. Palayew A, Norgaard O, Safreed-Harmon K, Andersen TH, Rasmussen LN, Lazarus JV. Pandemic publishing poses a new covid-19 challenge. Nat Hum Behav. 2020:666–9. https://doi.org/10.1038/s41562-020-0911-0. · DOI · Paper page
  33. Pederson T. Publishing coronavirology: Peering into peer(less?) review. FASEB J. 2020; 34(8):9825–7. https://doi.org/10.1096/fj.202001592. · DOI
  34. Journal of Critical Care, COVID-19 Update. Elsevier. https://www.journals.elsevier.com/journal-of-critical-care/covid-19. Accessed 20 July 2020.
  35. COVID-19 Articles Accepted for Fast-Track Publication in Psychological Science. Psychological Science. SAGE. https://journals.sagepub.com/page/pss/covid-19. Accessed 20 July 2020.
  36. Homolak J, Kodvanj I, Virag D. Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders. Scientometrics. 2020; 124:2687–701. https://doi.org/10.1007/s11192-020-03587-2. · DOI · Paper page
  37. Aviv A. Telomeres and COVID-19. FASEB J. 2020; 34(6):7247–52. https://doi.org/10.1096/fj.202001025. · DOI · Paper page
  38. Committee on Publication Ethics. A short guide to ethical editing for new editors. https://doi.org/10.24318/cope.2019.1.8. https://publicationethics.org/node/19871. · doi:10.24318/cope.2019.1.8
  39. Risch HA. Opinion: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis. Am J Epidemiol. 2020; 189(11):1218–26. https://doi.org/10.1093/aje/kwaa093. · DOI
  40. Fox MP, D’Agostino McGowan L, James BD, Lessler J, Mehta SH, Murray EJ. Concerns About the Special Article on Hydroxychloroquine and Azithromycin in High Risk Outpatients with COVID-19 by Dr. Harvey Risch. Am J Epidemiol. 2021; 190(4):491–5. https://doi.org/10.1093/aje/kwaa189. · DOI
  41. Machiels JD, Bleeker-Rovers CP, ter Heine R, Rahamat-Langendoen J, de Mast Q, ten Oever J, Bousema T, van Crevel R, Wertheim HF. Reply to Gautret et al.: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?Int J Antimicrob Agents. 2020; 56(1):106056. https://doi.org/10.1016/j.ijantimicag.2020.106056. · DOI
  42. Voss A, Coombs G, Unal S, Saginur R, Hsueh P-R. Publishing in face of the COVID-19 pandemic. Int J Antimicrob Agents. 2020; 56(1):106081. https://doi.org/10.1016/j.ijantimicag.2020.106081. · doi:10.1016/j.ijantimicag.2020.106081
  43. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020; 382(26):2582. https://doi.org/10.1056/NEJMc2021225. · DOI · Paper page
  44. Mahase E. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk. BMJ. 2020; 369. https://doi.org/10.1136/bmj.m2126. · doi:10.1136/bmj.m2126
  45. Hardwicke TE, Goodman SN. How often do leading biomedical journals use statistical experts to evaluate statistical methods? the results of a survey. PLoS ONE. 2020; 15(10):1–12. https://doi.org/10.1371/journal.pone.0239598. · DOI
  46. The BMJ Editorial Board. https://www.bmj.com/about-bmj/editorial-staff. (Accessed 15 July 2020).
  47. Pardo R, Algara M, Montero-Fernández MA, Sanz X, Vernet M, Rodríguez N, Andrés-Luna R, Piñero A, Ciérvide R, Córdoba R, et al.Diagnosis and locoregional treatment of patients with breast cancer during the COVID-19 pandemic. Revista de Senologia y Patologia Mamaria. 2020; 33(2):61–7. https://doi.org/10.1016/j.senol.2020.04.002. · doi:10.1016/j.senol.2020.04.002
  48. Review Commons. 2020. https://www.reviewcommons.org/about/.
  49. Pucker B, Schilbert HM, Schumacher SF. Integrating Molecular Biology and Bioinformatics Education. J Integr Bioinforma. 2019; 16(3). https://doi.org/10.1515/jib-2019-0005. · DOI
  50. Jansen Y, Hornbaek K, Dragicevic P. What Did Authors Value in the CHI’16 Reviews They Received? In: Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems: 2016. p. 596–608. https://doi.org/10.1145/2851581.2892576. · doi:10.1145/2851581.2892576
  51. Squazzoni F, Grimaldo F, Marušić A. Publishing: Journals could share peer-review data. Nature. 2017; 546:352. · DOI
  52. McNutt M. Journals unite for reproducibility. Nature. 2014; 515:7. https://doi.org/10.1038/515007a. · DOI
  53. Blumzon CFI, Pănescu AT. Data Storage. Cham: Springer; 2020, pp. 277–97. https://doi.org/10.1007/164\_2019\_28. · doi:10.1007/164_2019_28
  54. Asendorpf JB, Conner M, De Fruyt F, De Houwer J, Denissen JJA, Fiedler K, Fiedler S, Funder DC, Kliegl R, Nosek BA, Perugini M, Roberts BW, Schmitt M, van Aken MAG, Weber H, Wicherts JM. Recommendations for increasing replicability in psychology. Eur J Personal. 2013; 27(2):108–19. https://doi.org/10.1002/per.1919. · DOI · Paper page
  55. Begley CG, Ioannidis JP. Reproducibility in science: improving the standard for basic and preclinical research. Circ Res. 2015; 116(1):116–26. https://doi.org/10.1161/CIRCRESAHA.114.303819. · DOI · Paper page
  56. Li R, von Isenburg M, Levenstein M, Neumann S, Wood J, Sim I. Covid-19 trials: declarations of data sharing intentions at trial registration and at publication. Trials. 2021; 22(153). https://doi.org/10.1186/s13063-021-05104-z. · DOI
  57. Johnson AE, Pollard TJ, Shen L, Li-Wei HL, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, Mark RG. MIMIC-III, a freely accessible critical care database. BSci data. 2016; 3. https://doi.org/10.1038/sdata.2016.35. · DOI · Paper page
  58. Easterbrook SM. Open code for open science?Nat Geosci. 2014; 7(11):779–81. https://doi.org/10.1038/ngeo2283. · DOI
  59. Gilroy SP, Kaplan BA. Furthering open science in behavior analysis: An introduction and tutorial for using GitHub in research. Perspect Behav Sci. 2019; 42(3):565–81. https://doi.org/10.1007/s40614-019-00202-5. · DOI
  60. Perkel J. Democratic databases: science on GitHub. Nature. 2016; 538(7623):127–8. https://doi.org/10.1038/538127a. · DOI
  61. Wiley’s Data Sharing Policies. https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/data-sharing-citation/data-sharing-policy. html. (Accessed 15 July 2020).
  62. Murcott THL, Williams A. The challenges for science journalism in the UK. Prog Phys Geogr: Earth Environ. 2013; 37(2):152–60. https://doi.org/10.1177/0309133312471285. · DOI
  63. Fry NK, Marshall H, Mellins-Cohen T. In praise of preprints. Microb Genomics. 2019; 5(4). https://doi.org/10.1099/mgen.0.000259. · DOI
  64. Kwon D. How swamped preprint servers are blocking bad coronavirus research. Nature. 2020. https://doi.org/10.1038/d41586-020-01394-6. · DOI · Paper page
  65. Johansson MA, Reich NG, Meyers LA, Lipsitch M. Preprints: An underutilized mechanism to accelerate outbreak science. PLoS Med. 2018; 15(4):1002549. https://doi.org/10.1371/journal.pmed.1002549. · DOI · Paper page
  66. Gautret P, Lagier J-C, Parola P, Hoang VT, Medded L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Esteves Vieira V, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain J-M, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949. · DOI · Paper page
  67. Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020; 16(7):659–66. https://doi.org/10.1080/1744666X.2020.1792778. PMID: 32620062. · DOI
  68. Bae S, Kim MC, Kim JY, Cha HH, Lim JS, Jung J, Kim MJ, Oh DK, Lee M-K, Choi S-H, Sung M, Hong SB, Chung JW, Kim SH. Effectiveness of surgical and cotton masks in blocking SARS–CoV-2: a controlled comparison in 4 patients. Ann Intern Med. 2020; 173(1):22–3. https://doi.org/10.7326/M20-1342. PMID: 32251511. · DOI · Paper page
  69. Sheldon T. Preprints could promote confusion and distortion. Nature. 2018; 559(7714):445–6. https://doi.org/10.1038/d41586-018-05789-4. · DOI
  70. Dumas-Mallet E, Smith A, Boraud T, Gonon F. Scientific uncertainty in the press: How newspapers describe initial biomedical findings. Sci Commun. 2018; 40(1):124–41. https://doi.org/10.1177/1075547017752166. · DOI
  71. Meier K, Schützeneder J. Bridging the gaps: Transfer between scholarly research and newsrooms in journalism education–toward an evidence-based practice in an age of post-truth and state of flux. Journal Mass Commun Educ. 2019; 74(2):199–211. https://doi.org/10.1177/1077695819830021. · doi:10.1177/1077695819830021
  72. Miranda GF, Vercellesi L, Bruno F. Information sources in biomedical science and medical journalism: methodological approaches and assessment. Pharmacol Res. 2004; 50(3):267–72. https://doi.org/10.1016/j.phrs.2003.12.021. · DOI
  73. Peláez AL, Díaz JA. Science, technology and democracy: Perspectives about the complex relation between the scientific community, the scientific journalist and public opinion. Soc Epistemol. 2007; 21(1):55–68. https://doi.org/10.1080/02691720601125548. · doi:10.1080/02691720601125548
  74. Chalaud D, Aghan D, Otindo V, Bennett A, Baldet T. Ebola: improving science-based communication and local journalism. Lancet. 2015; 386(10009):2139. https://doi.org/10.1016/S0140-6736(15)01047-8. · doi:10.1016/s0140-6736(15)01047-8
  75. La V-P, Pham T-H, Ho M-T, Nguyen M-H, P Nguyen K-L, Vuong T-T, Nguyen H-KT, Tran T, Khuc Q, Ho M-T, Vuong Q-H. Policy response, social media science journalism for the sustainability of the public health system amid the COVID-19 outbreak: the Vietnam lessons. Sustainability. 2020; 12(7). https://doi.org/10.3390/su12072931. · DOI · Paper page
  76. Smeros P, Castillo C, Aberer K. Scilens: Evaluating the quality of scientific news articles using social media and scientific literature indicators. In: The World Wide Web Conference WWW ’19. New York, NY, USA: Association for Computing Machinery: 2019. p. 1747–58. https://doi.org/10.1145/3308558.3313657. · DOI
  77. Vraga EK, Tully M, Bode L. Empowering users to respond to misinformation about COVID-19. Media Commun. 2020; 8(2):475–9. https://doi.org/10.17645/mac.v8i2.3200. · DOI
  78. Jeschke JM, Lokatis S, Bartram I, Tockner K. Knowledge in the dark: scientific challenges and ways forward. FACETS. 2019; 4(1):423–41. https://doi.org/10.1139/facets-2019-0007. · DOI
  79. Kowalczyk O, Lautarescu A, Blok E, Dall’Aglio L, Westwood SJ. What senior academics can do to support reproducible and open research: a short, three-step guide. PsyArXiv. 2020. https://doi.org/10.31234/osf.io/jyfr7. · DOI
  80. Thorp HH. Science has always been political. Science. 2020; 369(6501):227. https://doi.org/10.1126/science.abd7628. · doi:10.1126/science.abd7628
  81. Kickbusch I. Politics or technocracy – what next for global health?; comment on navigating between stealth advocacy and unconscious dogmatism: The challenge of researching the norms, politics and power of global health. Int J Health Policy Manag. 2016; 5(3):201–4. https://doi.org/10.15171/ijhpm.2015.209. · doi:10.15171/ijhpm.2015.209

Cited by

See all 249

Metadata

Authors
Besançon, L., Peiffer-Smadja, N., Segalas, C., Jiang, H., Masuzzo, P., Smout, C., Billy, E., Deforet, M., & Leyrat, C.
Venue
BMC Medical Research Methodology
Published
2021-06-05
Volume
21
Issue
1
Pages
117-117
ISSN
1471-2288 (ISSN-L)
OpenAlex
W3171995498
Cited by
249
References
24
FWCI
43.05
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Open science saves lives: lessons from the COVID-19 pandemic. https://app.cochat.ai/papers/10.1186/s12874-021-01304-y
The paper
Besançon, L., Peiffer-Smadja, N., Segalas, C., Jiang, H., Masuzzo, P., Smout, C., Billy, E., Deforet, M., & Leyrat, C. (2021). Open science saves lives: lessons from the COVID-19 pandemic. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-021-01304-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.